Free Trial
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$0.79
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$0.79
$0.79
50-Day Range
$0.50
$0.80
52-Week Range
$0.55
$1.75
Volume
N/A
Average Volume
3,162 shs
Market Capitalization
$4.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About EKIMAS

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

ASNB Stock Price History

ASNB Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
EKIMAS Corporation (ASNB)
See More Headlines
Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/16/2014
Today
7/27/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Business Services
Current Symbol
OTCMKTS:ASNB
Employees
11
Year Founded
N/A

Profitability

Net Income
$-290,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.03 per share

Miscellaneous

Free Float
5,347,000
Market Cap
$4.58 million
Optionable
Not Optionable
Beta
0.37
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Henrik Rouf
    Chief Executive Officer
  • Bennett J. Yankowitz
    Chief Financial Officer & Director

ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed this year?

EKIMAS's stock was trading at $0.62 at the beginning of the year. Since then, ASNB stock has increased by 27.4% and is now trading at $0.79.
View the best growth stocks for 2024 here
.

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) posted its earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.02.

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG) and Sphere 3D (ANY).

This page (OTCMKTS:ASNB) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners